Top

International Journal of Clinical Oncology

Published in:

01-04-2011 | Review Article

A novel hyperthermia treatment for bone metastases using magnetic materials

Authors: Akihiko Matsumine, Kenji Takegami, Kunihiro Asanuma, Takao Matsubara, Tomoki Nakamura, Atsumasa Uchida, Akihiro Sudo

Published in: International Journal of Clinical Oncology | Issue 2/2011

Abstract

Patients with bone metastases in the extremities sometimes require surgical intervention to prevent deterioration of quality of life due to a pathological fracture. The use of localized radiotherapy combined with surgical reinforcement has been a gold standard for the treatment of bone metastases. However, radiotherapy sometimes induces soft tissue damage, including muscle induration and joint contracture. Moreover, cancer cells are not always radiosensitive. Hyperthermia has been studied since the 1940s using an experimental animal model to treat various types of advanced cancer, and studies have now reached the stage of clinical application, especially in conjunction with radiotherapy or chemotherapy. Nevertheless, bone metastases have several special properties which discourage oncologists from developing hyperthermic therapeutic strategies. First, the bone is located deep in the body, and has low thermal conductivity due to the thickness of cortical bone and the highly vascularized medulla. To address these issues, we developed new hyperthermic strategies which generate heat using magnetic materials under an alternating electromagnetic field, and started clinical application of this treatment modality. The purpose of this review is to summarize the latest studies on hyperthermic treatment in the field of musculoskeletal tumors, and to introduce the treatment strategy employing our novel hyperthermia approach.

Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12(Suppl):S6243–S6249CrossRef

Fidler M (1981) Incidence of fracture through metastases in long bones. Acta Orthop Scand Dec 52:623–627CrossRef

Frassica DA, Frassica FJ (1998) Nonoperative management. In: Simon MA, Springfield D (eds) Surgery for bone and soft-tissue tumors. Lippincott-Raven, Philadelphia, pp 633–637

Yazawa Y, Frassica FJ, Chao EY et al (1990) Metastatic bone disease. A study of the surgical treatment of 166 pathologic humeral and femoral fractures. Clin Orthop Relat Res 251:213–219PubMed

van der Zee J (2002) Heating the patient: a promising approach? Ann Oncol 13:1173–1184PubMedCrossRef

Harmon BV, Corder AM, Collins RJ et al (1990) Cell death induced in a murine mastocytoma by 42–47 degrees C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load. Int J Radiat Biol 58:845–858PubMedCrossRef

Robins HI, D’Oleire F, Grosen E et al (1997) Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease. Anticancer Res 17:2891–2894PubMed

Sellins KS, Cohen JJ (1991) Hyperthermia induces apoptosis in thymocytes. Radiat Res 126:88–95PubMedCrossRef

Rau B, Wust P, Hohenberger P et al (1998) Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: a phase II clinical trial. Ann Surg 227:380–389PubMedCrossRef

10.

Grunhagen DJ, de Wilt JH, Graveland WJ et al (2006) Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma. Cancer 106:1776–1784PubMedCrossRef

11.

Fan QY, Ma BA, Qlu XC et al (1996) Preliminary report on treatment of bone tumors with microwave-induced hyperthermia. Bioelectromagnetics 17:218–222PubMedCrossRef

12.

Sakurai H, Hayakawa K, Mitsuhashi N et al (2002) Effect of hyperthermia combined with external radiation therapy in primary non-small cell lung cancer with direct bony invasion. Int J Hyperthermia 18:472–483PubMedCrossRef

13.

Malawer MM, Marks MR, McChesney D et al (1988) The effect of cryosurgery and polymethylmethacrylate in dogs with experimental bone defects comparable to tumor defects. Clin Orthop Relat Res 226:299–310PubMed

14.

Sturup J, Nimb L, Kramhoft M et al (1994) Effects of polymerization heat and monomers from acrylic cement on canine bone. Acta Orthop Scand 65:20–23PubMedCrossRef

15.

Kusaka M, Takegami K, Sudo A et al (2002) Effect of hyperthermia by magnetite cement on tumor-induced bone destruction. J Orthop Sci 7:354–357PubMedCrossRef

16.

Vogl TJ, Mack MG, Straub R et al (2001) MR-guided laser-induced thermotherapy of the infratemporal fossa and orbit in malignant chondrosarcoma via a modified technique. Cardiovasc Intervent Radiol 24:432–435PubMedCrossRef

17.

Groenemeyer DH, Schirp S, Gevargez A (2002) Image-guided percutaneous thermal ablation of bone tumors. Acad Radiol 9:467–477PubMedCrossRef

18.

Takegami K, Sano T, Wakabayashi H et al (1998) New ferromagnetic bone cement for local hyperthermia. J Biomed Mater Res 43:210–214PubMedCrossRef

19.

Uchida A, Wakabayashi H, Okuyama N et al (2004) Metastatic bone disease: pathogenesis and new strategies for treatment. J Orthop Sci 9:415–420PubMedCrossRef

20.

Morita K, Morita S, Tsujiguchi M et al (2002) A method of local hyperthermia with ferromagnetic bone cement. Improvement for clinical medicine. Orthopaedic Ceramic Implants 19–20:97–100

21.

Matsumine A, Kusuzaki K, Matsubara T et al (2007) Novel hyperthermia for metastatic bone tumors with magnetic materials by generating an alternating electromagnetic field. Clin Exp Metastasis 24:191–200PubMedCrossRef

22.

Ivkov R, DeNardo SJ, Daum W et al (2005) Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer. Clin Cancer Res 11:7093s–7103sPubMedCrossRef

23.

Ito A, Shinkai M, Honda H et al (2005) Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 100:1–11PubMedCrossRef

24.

Kawashita M, Tanaka M, Kokubo T et al (2005) Preparation of ferrimagnetic magnetite microspheres for in situ hyperthermic treatment of cancer. Biomaterials 26:2231–2238PubMedCrossRef

25.

Yan S, Zhang D, Gu N et al (2005) Therapeutic effect of Fe₂O₃ nanoparticles combined with magnetic fluid hyperthermia on cultured liver cancer cells and xenograft liver cancers. J Nanosci Nanotechnol. 5:1185–1192PubMedCrossRef

26.

Hilger I, Hergt R, Kaiser WA (2000) Effects of magnetic thermoablation in muscle tissue using iron oxide particles: an in vitro study. Invest Radiol 35:170–179PubMedCrossRef

27.

Johannsen M, Gneveckow U, Eckelt L et al (2005) Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia 21:637–647PubMedCrossRef

28.

Kokubo T (1991) Bioactive glass ceramics: properties and applications. Biomaterials 12:155–163PubMedCrossRef

29.

Kapp DS (1989) Indications for the clinical use of deep local and regional hyperthermia in conjunction with radiation therapy. Strahlenther Onkol 165:724–728PubMed

30.

Ikenaga M, Ohura K, Kotoura Y et al (1994) Hyperthermic treatment of canine tibia through RF inductive heating of an intramedullary nail: a new experimental approach to hyperthermia for metastatic bone tumours. Int J Hyperthermia 10:507–516PubMedCrossRef

31.

Ikenaga M, Ohura K, Yamamuro T et al (1993) Localized hyperthermic treatment of experimental bone tumors with ferromagnetic ceramics. J Orthop Res 1:849–855CrossRef

32.

Kawanabe K, Tamura J, Yamamuro T et al (1993) A new bioactive bone cement consisting of BIS-GMA resin and bioactive glass powder. J Appl Biomater 4:135–141PubMedCrossRef

33.

Akagi M, Tsuboyama T, Ikenaga M et al (1997) Anti-tumour effects of localized hyperthermia on an experimental bone tumour using an intramedullary nail. Int J Hyperthermia 13:387–400PubMedCrossRef

34.

Matsumine A, Kusuzaki K, Matsubara T et al (2006) Calcium phosphate cement in musculoskeletal tumor surgery. J Surg Oncol 93:212–220PubMedCrossRef

35.

Morita K, Uchida A (2002) The treatment of bone tumors with the local hyperthermia using calcium phosphate cement containing ferromagnetite. J Musculoskelet Syst 15:443–445

36.

Pennacchioli E, Fiore M, Gronchi A (2009) Hyperthermia as an adjunctive treatment for soft-tissue sarcoma. Expert Rev Anticancer Ther 9:199–210PubMedCrossRef

37.

Otsuka T, Yonezawa M, Kamiyama F et al (2001) Results of surgery and radio-hyperthermo-chemotherapy for patients with soft-tissue sarcoma. Int J Clin Oncol. 6:253–258PubMedCrossRef

38.

Stauffer PR (2005) Evolving technology for thermal therapy of cancer. Int J Hyperthermia 21:731–744PubMedCrossRef

39.

Coleman R, Rubens R (1987) The clinical course of bone metastases in breast cancer. Br J Cancer 77:336–340CrossRef

40.

Fan K, Peng CF (1983) Predicting the probability of bone metastasis through histological grading of prostate carcinoma: a retrospective correlative analysis of 81 autopsy cases with antemortem transurethral resection specimen. J Urol 130:708–711PubMed

Title: A novel hyperthermia treatment for bone metastases using magnetic materials
Authors: Akihiko Matsumine
Kenji Takegami
Kunihiro Asanuma
Takao Matsubara
Tomoki Nakamura
Atsumasa Uchida
Akihiro Sudo
Publication date: 01-04-2011
Publisher: Springer Japan
Published in: International Journal of Clinical Oncology / Issue 2/2011
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-011-0217-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2011

Full-thickness chest-wall resection followed by thorax reconstruction for recurrent malignant phyllodes tumor

Basic science and clinical frontiers of sarcoma treatment

Announcing our new journal: International Cancer Conference Journal (ICCJ)

Cryoimmunology for malignant bone and soft-tissue tumors

Metastatic collecting duct carcinoma of the kidney responded to sunitinib

Inhibitory effects of dietary glucosylceramides on squamous cell carcinoma of the head and neck in NOD/SCID mice

Keynote webinar | Spotlight on antibody–drug conjugates in cancer